Rebollo-Román, AngelAlhambra-Expósito, Maria RHerrera-Martínez, YiraldineLeiva-Cepas, FAlzas, CarlosMuñoz-Jiménez, ConcepcionOrtega-Salas, RMolina-Puertas, María JGálvez-Moreno, Maria AHerrera-Martínez, Aura D2025-01-072025-01-072021-09-081664-2392https://hdl.handle.net/10668/28342The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents in some cases with hemostatic and thrombotic complications. Pheochromocytomas are unusual, though potentially lethal tumors. Herein we describe the first case of hemorrhage in a pheochromocytoma related to SARS-CoV-2 infection. A 62-year-old man consulted for syncope, fever, and palpitations. He was diagnosed with SARS-CoV-2 pneumonia and presented with a hemorrhage in a previously unknown adrenal mass, which resulted in a catecholaminergic crisis. Medical treatment and surgery were required for symptom control and stabilization. We hereby alert clinicians to watch for additional/unreported clinical manifestations in COVID-19 infection.enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/COVID19bleedingcatecholaminescomplicationpheochromocytomaAdrenal Gland NeoplasmsCOVID-19HemorrhageHumansMaleMiddle AgedPheochromocytomaPneumoniaresearch article34566886open access10.3389/fendo.2021.693004PMC8456100https://www.frontiersin.org/articles/10.3389/fendo.2021.693004/pdfhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8456100/pdf